Lyra Therapeutics Competitors and Similar CompaniesClear all
Intersect ENT's competitors and similar companies include Acorda Therapeutics, Codiak Biosciences and Spur Therapeutics.
 Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. | |
Founding Date | Founding Date 2003 | Founding Date 1995 | Founding Date 2015 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Menlo Park, US HQ | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Cambridge, US HQ | Locations Stevenage, GB HQ Boston, US New York, US |
Employees | Employees 4337% increase | Employees 4742% decrease | Employees 992% decrease | Employees 122 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 821 k | Valuation ($) 2.8 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods $15.3m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $76.7m (FY, 2021) | Gross profit N/A | Gross profit N/A | Gross profit $8.9m (FY, 2022) |
Net income | Net income ($159.6m) (FY, 2021) | Net income ($252.9m) (FY, 2023) | Net income ($37.2m) (FY, 2021) | Net income ($89m) (FY, 2022) |
Operating ⚠ | ||||
Products | Products 2 (FY, 2016) | Products N/A | Products 11 (Q2, 2020) | Products N/A |
Trademarks | Trademarks 29 (FY, 2016) | Trademarks N/A | Trademarks N/A | Trademarks 14 (May, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 102.9m | Total funding raised N/A | Total funding raised $ 168.5m | Total funding raised $ 289.3m |
For sources of this data, please see the company profile
View Company Profiles
Acorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companySpur Therapeutics
HQ
Stevenage, GB
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View company